- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Mitochondrial-Derived Peptide · Educational Resource
Understanding MOTS-C and Mitochondrial Research
Mitochondrial-Derived Peptide
(Synthetic Peptide)
Investigational Application
Mitochondrial, metabolic function research
Administration Protocol
Subcutaneous (subQ), per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Mitochondrial-Derived Peptide · Educational Resource
Understanding MOTS-C and Mitochondrial Research
01 — Overview
What is MOTS-C?
MOTS-C is a synthetic peptide modeled after a naturally occurring mitochondrial-derived peptide, encoded within a small region of mitochondrial DNA rather than the cell nucleus.
As an investigational compound, MOTS-C has not received regulatory approval for therapeutic use in the Philippines or elsewhere. It should be understood strictly as a research compound studied in preclinical contexts.
Within research literature, MOTS-C is most frequently studied for its relationship to mitochondrial function and metabolic regulation, areas summarized further below.
02 — How it works
How It Works: Mitochondrial-Nuclear Signaling and Metabolic Regulation
As a mitochondrial-derived peptide, MOTS-C is studied for its ability to translocate to the cell nucleus under conditions of metabolic stress, where researchers investigate its role in regulating gene expression related to metabolism.
Literature describes this mitochondrial-nuclear communication as a novel signaling mechanism distinct from conventional hormone or growth factor pathways, positioning MOTS-C within an emerging research category of mitochondrial-derived peptides.
Administration in Research
In preclinical literature, MOTS-C is evaluated as a subcutaneous injection administered within controlled research protocols. As an investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Preclinical literature evaluates MOTS-C across several key physiological parameters to map its biological interactions:
Mitochondrial-Nuclear Signaling Pathways
Research literature evaluates how MOTS-C, encoded within mitochondrial DNA, is studied as a signaling molecule that communicates between mitochondria and the cell nucleus.
Glucose Metabolism Parameters
Preclinical studies observe markers of glucose uptake and insulin sensitivity associated with MOTS-C exposure in research models.
AMPK Pathway Activation
Investigational literature examines MOTS-C's studied relationship to AMPK, a cellular energy-sensing pathway.
Exercise Adaptation Research
Studies explore MOTS-C levels in relation to physical activity and exercise adaptation in research models.
Age-Related Metabolic Studies
Literature investigates MOTS-C's studied decline with age and its relationship to age-associated metabolic changes.
Pharmacokinetic Profiling
Studies characterize the absorption and elimination profile of MOTS-C in research settings.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Lee, C., et al. (2015). The Mitochondrial-Derived Peptide MOTS-C Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism.
Reynolds, J.C., et al. (2021). MOTS-C Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis. Nature Communications.
Kim, K.H., et al. (2018). Mitochondrial-Derived Peptides in Aging and Age-Related Diseases. GeroScience.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
